🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at age 51 after a personal fight with pancreatic cancer.

“The brilliant light of our family has faded away for us in this life,” his family stated. “After a prolonged and courageous battle with cancer, we are deeply saddened to declare that D’Angelo, known to his fans around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on music with his innovative modern soul style and partnerships with renowned musicians.

He released his first record, “Brown Sugar,” in 1995 to immediate acclaim. The album reached the fourth spot on Billboard’s Top R&B Albums chart, earned platinum status soon after, and received multiple award nominations.

However, it was his second album, “Voodoo,” in 2000 that boosted his artistic journey into the limelight. The record debuted at No. 1 on each of Billboard’s Top R&B Albums chart and the main album chart. He won two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a hesitant one, in the cultural zeitgeist. The intimate portrayal featured the artist, famously stripped down to his midsection, singing directly into the camera.

D’Angelo stepped back from the spotlight after releasing Voodoo and publicly struggled with drugs and alcohol. In 2005, he was part of a severe vehicle accident that put him in grave health.

More than a decade later, his last record, “Black Messiah” (2014), reaffirmed his enduring appeal with a further top chart entry on the soul music rankings and a award for Top R&B Record.

Again, in his own enigmatic way, D’Angelo made only a few public outings in the following years.

The singer was scheduled as a top act for the 2025 music event, but his performance was canceled, due to an “unexpected health issue.”

Even though information is limited about D’Angelo’s well-being in the weeks before his death, he had apparently been in the hospital for months and in hospice for two weeks.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic malignancy, one of the most deadly and hardest to prevent types of the disease, on a gifted artist whose existence was ended too soon.

“We are grieved that he can only provide dear memories with his family, but we are eternally grateful for the legacy of extraordinarily moving music he has left us,” his kin expressed.

Pancreatic Malignancy: Lethal and Difficult to Avoid

Pancreatic malignancy affects the digestive organ, a small organ that produces the hormone insulin and plays an essential role in digestion, among other functions. The size and location of the pancreas in the human system make it more difficult to detect malignancy.

Even though pancreatic cancer makes up only about 3% of cancer diagnoses each year in the United States, it is responsible for 7% of cancer deaths.

Nearly 70,000 individuals will be diagnosed with pancreatic cancer and about fifty-two thousand will die of the disease in the year 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and dismal outcomes. We have limited and poor treatment options, and a narrow opportunity to make a meaningful impact on the well-being of people,” noted a cancer specialist.

Because this disease rarely causes early symptoms, it’s frequently identified only after the disease is advanced. Even when a patient has symptoms they are usually vague and may be mistaken for a several everyday ailments.

“Currently, there is no effective method to identify this malignancy in the initial phases, except for listening to your body and speaking with your physician if there are new or unusual signs,” said a health expert.

Frequent indicators of this disease include:

• discomfort in the stomach or back
• reduced body mass
• yellowing of skin and eyes
• reduced hunger
• dark urine
• light-colored or greasy stools
• loose stools
• excessive hunger or thirst
• nausea

At 51 years old, D’Angelo’s death is an exception, as pancreatic cancer is most common in individuals in the 65 to 75 range. However, numerous malignancies, such as this type, have become more common in younger people.

“Pancreatic cancer diagnosed prior to fifty is considered uncommon, yet concerningly, clinicians are beginning to see a rising count of younger individuals suffering from this condition,” commented a specialist.

Family History Impacts Disease Probability

Without effective screening tools for pancreatic cancer, professionals stressed the significance of knowing your relatives’ health background. Some contributing elements, such as smoking and excess weight also have an influence in the onset of pancreatic cancer.

African Americans have the highest incidence of this malignancy in the United States and are more prone to be found to have untreatable disease.

“The initial action toward lowering one’s chance of pancreatic cancer is understanding personal risk factors. Individuals should review their genetic background, genetic background, and health issues, such as blood sugar disease, long-term pancreas inflammation, or overweight that may raise their susceptibility,” advised a specialist.

Hereditary risk factors are linked to as much as 10% of all this malignancy cases. If a relative in your household has had pancreatic cancer, you may want to think about genetic testing.

“For people with a family history of this condition or those having high risk DNA changes, checking may involve advanced imaging such as MRI scans or internal ultrasound to detect early changes in the organ,” he explained.

For those looking to reduce their risk, habit adjustments may have an effect. The best step you can take to reduce your susceptibility of pancreatic cancer is to quit smoking, and if you don’t smoke, avoid exposure altogether.

Heavy alcohol consumption is linked to pancreas inflammation, a risk factor for this malignancy, so limiting or abstaining from drinks may assist lower your chance.

Managing your weight or losing weight may also help reduce your risk. People with obesity are 20% more likely to develop this disease. This malignancy also is more frequent in people with diabetes, and reducing weight can also reduce the risk of type 2 diabetes.

In spite of this disease’s grim outlook, there is still hope.

“We are making progress with treatments and more recent mixed drug treatments. There are emerging targeted therapies that are already showing results,” said a specialist.

For numerous individuals, however, awareness about this uncommon but {dev